3-amino-N-(naphthalen-2'-yl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]thieno[3,2-e]pyridine-2-carboxamide | 354119-17-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 3-amino-N-(naphthalen-2'-yl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]thieno[3,2-e]pyridine-2-carboxamide
• 英文别名: 3-amino-N-(2-naphthyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]thieno[3,2-e]pyridine-2-carboxamide；6-amino-N-naphthalen-2-yl-4-thia-2-azatricyclo[7.5.0.03,7]tetradeca-1,3(7),5,8-tetraene-5-carboxamide
• CAS: 354119-17-8
• 化学式: C₂₃H₂₁N₃OS
• mdl: MFCD01994728
• 分子量: 387.505
• InChiKey: KSOLAGYMXZLXFZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.3
• 重原子数：
  28
• 可旋转键数：
  2
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  96.2
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  环庚酮 在 哌啶 、 甲醇 、 sodium 、 sodium carbonate 、 溶剂黄146 作用下， 以 乙醇 、 水 为溶剂， 反应 22.0h， 生成 3-amino-N-(naphthalen-2'-yl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]thieno[3,2-e]pyridine-2-carboxamide
  参考文献：
  名称：

  噻吩并[2,3 - b ]喹啉-2-羧酰胺和环烷基[ b ]噻吩并[3,2 - e ]吡啶-2-羧酰胺衍生物的合成及细胞毒性

  摘要：

  噻吩并[2,3-的七十九衍生物b〕喹啉，四氢[2,3- b ]喹啉，二氢环戊二烯并[ b ]噻吩并[3,2- ë ]吡啶，环庚并[ b ]噻吩并[3,2- ë ]吡啶和六氢环辛基[ b ]噻吩并[3,2- e ]吡啶是合成的或可商购的，并测试了它们对HCT116，MDA-MB-468和MDA-MB-231人癌细胞系的抗增殖活性。最有效的八种化合物对所有细胞系均具有活性，IC 50值在80–250 nM范围内。一般而言，六氢环辛基[ b ]噻吩并[3,2- e当较大的环烷基环与吡啶环稠合时，]吡啶最活跃，活性增加。

  DOI：

  10.1016/j.bmc.2016.01.047

文献信息

• Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections
  申请人：Siga Technologies, Inc.

  公开号：US20130129677A1

  公开（公告）日：2013-05-23

  Methods and pharmaceutical compositions for treating viral infections, by administering certain thienopyridine derivative compounds in therapeutically effective amounts are disclosed. Methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment of viral infections such as caused by flavivirus is disclosed, i.e., including but not limited to, Dengue virus, West Nile virus, yellow fever virus, Japanese encephalitis virus, and tick-borne encephalitis virus.

  本发明揭示了使用某些噻唑吡啶衍生物化合物以治疗病毒感染的方法和制药组合物，通过以治疗有效剂量给药。同时还揭示了使用这些化合物和制药组合物的方法。具体地，揭示了治疗由黄热病毒、日本脑炎病毒、西尼罗河病毒、登革热病毒和蜱媒脑炎病毒等引起的病毒感染的方法。
• THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS
  申请人：Siga Technologies, Inc.

  公开号：US20170121344A1

  公开（公告）日：2017-05-04

  Methods and pharmaceutical compositions for treating viral infections, by administering certain thienopyridine derivative compounds in therapeutically effective amounts are disclosed. Methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment of viral infections such as caused by flavivirus is disclosed, i.e., including but not limited to, Dengue virus, West Nile virus, yellow fever virus, Japanese encephalitis virus, and tick-borne encephalitis virus.
• [EN] THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS<br/>[FR] DÉRIVÉS DE THIÉNOPYRIDINE POUR LE TRAITEMENT ET LA PRÉVENTION D'INFECTIONS PAR LE VIRUS DE LA DENGUE
  申请人：SIGA TECHNOLOGIES INC

  公开号：WO2014089378A1

  公开（公告）日：2014-06-12

  Methods and pharmaceutical compositions for treating viral infections, by administering certain thienopyridine derivative compounds in therapeutically effective amounts are disclosed. Methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment of viral infections such as caused by flavivirus is disclosed, i.e., including but not limited to, Dengue virus, West Nile virus, yellow fever virus, Japanese encephalitis virus, and tick-borne encephalitis virus.